-

$undefined

N/A

(N/A)

LIXTE Biotechnology Holdings, Inc. :LIXT

Location: | Industry: | Sector:

Market Cap

NaN

52 Wk Range

$ - $

Previous Close

$N/A

Open

$N/A

Day Range

N/A - N/A

Volume

N/A

Avg Volume

N/A

Enterprise Value

5.789M

Cash

1.039M

Avg Qtr Burn

-791.1K

Short % of Float

1.19%

Insider Ownership

18.43%

Institutional Own.

15.75%

Qtr Updated

12/31/24

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
LB-100 + dostarlimab-gxly Details Cancer, Ovarian clear cell carcinoma	Phase 1/2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
LB-100 +atezolizumab Details Cancer, Metastatic colorectal cancer	Phase 1 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.